| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.84B | +37.0% |
| Cost of Revenue | $3.12B | +26.6% |
| Gross Profit | $714.2M | +114.3% |
| R&D Expense | $16.3M | -1.2% |
| SG&A Expense | $297.5M | +31.1% |
| Operating Income | $287.3M | +144.3% |
| Interest Expense | $92.1M | -5.6% |
| Pre-tax Income | $162.0M | +1428.3% |
| Income Tax | $15.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $584.0M | -15.1% |
| Accounts Receivable | $579.2M | +23.2% |
| Inventory | $1.20B | +14.3% |
| Current Assets | $2.48B | +7.4% |
| Total Assets | $4.45B | +3.7% |
| Current Liabilities | $963.9M | +12.6% |
| Long-term Debt | $1.71B | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $224.9M | +1296.9% |
| Investing Cash Flow | -$126.7M | -63.9% |
| Financing Cash Flow | -$201.9M | -296.0% |
| -42.2% |
| Net Income | $130.9M | +442.7% |
| EPS (Basic) | $1.03 | +443.3% |
| EPS (Diluted) | $0.96 | +420.0% |
| Total Liabilities |
| $3.29B |
| -4.8% |
| Stockholders' Equity | $1.05B | +52.6% |